A recent clinical trial conducted by drug manufacturer Eli Lilly has shown that their drug Zepbound is more effective for long-term weight loss compared to Wegovy. In the study, 20% of participants who took Zepbound experienced significant weight loss, while nearly 14% of those who took Wegovy achieved similar results.
The trial, which lasted for 72 weeks, included 751 individuals in the United States and Puerto Rico. These participants were either overweight or had obesity, along with at least one other health condition like hypertension, obstructive sleep apnea, or cardiovascular disease. Importantly, none of the participants had been diagnosed with diabetes.
Experts emphasize that weight loss drugs like Zepbound and Wegovy are most effective when combined with a healthy diet and regular exercise. Adequate sleep and stress management also play a crucial role in achieving successful long-term weight loss.
It’s essential for individuals considering weight loss medications to understand that these drugs require a long-term commitment. Starting at a low dose and gradually increasing it allows the body to adjust, and some patients may not see significant results until they reach higher doses. Additionally, many patients may regain weight after discontinuing these medications.
Zepbound, Wegovy, Ozempic, and Mounjaro are all weekly injectable drugs that mimic the effects of the gut hormone GLP-1 to suppress appetite. Tirzepatide, the key ingredient in Zepbound and Mounjaro, stimulates GIP and GLP-1 receptors to aid in weight loss.
While these medications can offer significant long-term weight loss benefits, they may also come with side effects such as nausea, constipation, abdominal pain, and fatigue. In severe cases, individuals may experience gastrointestinal issues.
Research has indicated that these drugs can not only aid in weight loss but also reduce the risk of cardiovascular disease and cancer, as well as potentially improve symptoms in conditions like rheumatoid arthritis. In fact, the FDA recently granted Novo Nordisk permission to list heart-related benefits on Wegovy’s label, highlighting the potential health benefits of these medications. sentence: Please ensure that the windows are closed before leaving the room.
